Specialty code 1835P0018X · Sacramento, CA
NPI
1407021892
Since 2008
Specialty
Specialty code 1835P0018X
Code 1835P0018X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3240 Arden Way
Sacramento, CA, 95825
Phone (916) 486-5256
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$268K
1,953 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Rosanna A Ulep prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 262 prescriptions and refills. In total Rosanna A Ulep wrote 1,953 Medicare prescriptions that cost $268K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Er Metformin Hcl | 262 | 870 | 111 | $2,547 |
| Atorvastatin Calcium Generic | 224 | 741 | 97 | $2,678 |
| Jardiance Empagliflozin | 201 | 656 | 80 | $117K |
| Glipizide Generic | 119 | 392 | 53 | $1,541 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 104 | 318 | 48 | $2,869 |
| Metformin Hcl Generic | 90 | 291 | 42 | $1,176 |
| Lisinopril Generic | 78 | 259 | 34 | $953 |
| Insulin Glargine-Yfgn Generic | 75 | 207 | 32 | $9,359 |
| Humulin R Insulin Regular, Human | 63 | 194 | 32 | $15K |
| Humulin N Insulin Nph Human Isophane | 58 | 173 | 28 | $13K |
| Amlodipine Besylate Generic | 54 | 180 | 25 | $747 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 49 | 130 | 22 | $1,033 |
| Victoza 2-Pak Liraglutide | 48 | 52 | 11 | $34K |
| Simvastatin Generic | 46 | 153 | 20 | $537 |
| Losartan Potassium Generic | 46 | 153 | 20 | $577 |
Brand drugs: 595 claims; generic drugs: 1,149 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rosanna A Ulep were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.